SYNAZE 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale — 1 flacon(s) en verre brun de 23 g avec pompe doseuse avec applicateur nasal polypropylène
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400927563348 -
CIP7
2756334 -
CIS
69043954
What the source publishes
- Holder
- VIATRIS MEDICAL
- Active ingredients
- CHLORHYDRATE D'AZÉLASTINE, PROPIONATE DE FLUTICASONE
- Form
- suspension pour pulvérisation
- Package
- 1 flacon(s) en verre brun de 23 g avec pompe doseuse avec applicateur nasal polypropylène
- Routes
- nasale
- Administrative status
- authorised
- Supply regime
- liste I
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2013-12-27
- Prescription
- Prescription or restricted
Names this record is found by
- SYNAZE 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale — 1 flacon(s) en verre brun de 23 g avec pompe doseuse avec applicateur nasal polypropylène
- SYNAZE 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale
- CHLORHYDRATE D'AZÉLASTINE
- PROPIONATE DE FLUTICASONE
Complete source data
{
"cis": "69043954",
"cip7": "2756334",
"form": "suspension pour pulvérisation",
"name": "SYNAZE 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale — 1 flacon(s) en verre brun de 23 g avec pompe doseuse avec applicateur nasal polypropylène",
"cip13": "3400927563348",
"holder": "VIATRIS MEDICAL",
"routes": [
"nasale"
],
"holders": [
"VIATRIS MEDICAL"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2013-12-27",
"compositions": [
{
"name": "CHLORHYDRATE D'AZÉLASTINE",
"nature": "SA",
"strength": "1000 microgrammes",
"linkageNumber": "1",
"substanceCode": "25329",
"dosageReference": "1 g de suspension",
"pharmaceuticalElement": "suspension"
},
{
"name": "PROPIONATE DE FLUTICASONE",
"nature": "SA",
"strength": "365 microgrammes",
"linkageNumber": "2",
"substanceCode": "41788",
"dosageReference": "1 g de suspension",
"pharmaceuticalElement": "suspension"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste I",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SYNAZE 137 microgrammes/50 microgrammes, suspension pour pulvérisation nasale",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "1 flacon(s) en verre brun de 23 g avec pompe doseuse avec applicateur nasal polypropylène",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2016-08-04",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"CHLORHYDRATE D'AZÉLASTINE",
"PROPIONATE DE FLUTICASONE"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"liste I"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400927563348"